Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7.

For over 30 years, HIV/AIDS has wreaked havoc in the world. In the absence of an effective vaccine for HIV, development of new anti-HIV agents is urgently needed. We previously identified the antiviral activities of the scorpion-venom-peptide-derived mucroporin-M1 for three RNA viruses (measles viru...

Full description

Bibliographic Details
Main Authors: Yaoqing Chen, Luyang Cao, Maohua Zhong, Yan Zhang, Chen Han, Qiaoli Li, Jingyi Yang, Dihan Zhou, Wei Shi, Benxia He, Fang Liu, Jie Yu, Ying Sun, Yuan Cao, Yaoming Li, Wenxin Li, Deying Guo, Zhijian Cao, Huimin Yan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3334916?pdf=render
_version_ 1818042627068526592
author Yaoqing Chen
Luyang Cao
Maohua Zhong
Yan Zhang
Chen Han
Qiaoli Li
Jingyi Yang
Dihan Zhou
Wei Shi
Benxia He
Fang Liu
Jie Yu
Ying Sun
Yuan Cao
Yaoming Li
Wenxin Li
Deying Guo
Zhijian Cao
Huimin Yan
author_facet Yaoqing Chen
Luyang Cao
Maohua Zhong
Yan Zhang
Chen Han
Qiaoli Li
Jingyi Yang
Dihan Zhou
Wei Shi
Benxia He
Fang Liu
Jie Yu
Ying Sun
Yuan Cao
Yaoming Li
Wenxin Li
Deying Guo
Zhijian Cao
Huimin Yan
author_sort Yaoqing Chen
collection DOAJ
description For over 30 years, HIV/AIDS has wreaked havoc in the world. In the absence of an effective vaccine for HIV, development of new anti-HIV agents is urgently needed. We previously identified the antiviral activities of the scorpion-venom-peptide-derived mucroporin-M1 for three RNA viruses (measles viruses, SARS-CoV, and H5N1). In this investigation, a panel of scorpion venom peptides and their derivatives were designed and chosen for assessment of their anti-HIV activities. A new scorpion venom peptide derivative Kn2-7 was identified as the most potent anti-HIV-1 peptide by screening assays with an EC(50) value of 2.76 µg/ml (1.65 µM) and showed low cytotoxicity to host cells with a selective index (SI) of 13.93. Kn2-7 could inhibit all members of a standard reference panel of HIV-1 subtype B pseudotyped virus (PV) with CCR5-tropic and CXCR4-tropic NL4-3 PV strain. Furthermore, it also inhibited a CXCR4-tropic replication-competent strain of HIV-1 subtype B virus. Binding assay of Kn2-7 to HIV-1 PV by Octet Red system suggested the anti-HIV-1 activity was correlated with a direct interaction between Kn2-7 and HIV-1 envelope. These results demonstrated that peptide Kn2-7 could inhibit HIV-1 by direct interaction with viral particle and may become a promising candidate compound for further development of microbicide against HIV-1.
first_indexed 2024-12-10T08:49:19Z
format Article
id doaj.art-512a5111e47e45cab10a46a5c9612cd3
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T08:49:19Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-512a5111e47e45cab10a46a5c9612cd32022-12-22T01:55:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0174e3494710.1371/journal.pone.0034947Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7.Yaoqing ChenLuyang CaoMaohua ZhongYan ZhangChen HanQiaoli LiJingyi YangDihan ZhouWei ShiBenxia HeFang LiuJie YuYing SunYuan CaoYaoming LiWenxin LiDeying GuoZhijian CaoHuimin YanFor over 30 years, HIV/AIDS has wreaked havoc in the world. In the absence of an effective vaccine for HIV, development of new anti-HIV agents is urgently needed. We previously identified the antiviral activities of the scorpion-venom-peptide-derived mucroporin-M1 for three RNA viruses (measles viruses, SARS-CoV, and H5N1). In this investigation, a panel of scorpion venom peptides and their derivatives were designed and chosen for assessment of their anti-HIV activities. A new scorpion venom peptide derivative Kn2-7 was identified as the most potent anti-HIV-1 peptide by screening assays with an EC(50) value of 2.76 µg/ml (1.65 µM) and showed low cytotoxicity to host cells with a selective index (SI) of 13.93. Kn2-7 could inhibit all members of a standard reference panel of HIV-1 subtype B pseudotyped virus (PV) with CCR5-tropic and CXCR4-tropic NL4-3 PV strain. Furthermore, it also inhibited a CXCR4-tropic replication-competent strain of HIV-1 subtype B virus. Binding assay of Kn2-7 to HIV-1 PV by Octet Red system suggested the anti-HIV-1 activity was correlated with a direct interaction between Kn2-7 and HIV-1 envelope. These results demonstrated that peptide Kn2-7 could inhibit HIV-1 by direct interaction with viral particle and may become a promising candidate compound for further development of microbicide against HIV-1.http://europepmc.org/articles/PMC3334916?pdf=render
spellingShingle Yaoqing Chen
Luyang Cao
Maohua Zhong
Yan Zhang
Chen Han
Qiaoli Li
Jingyi Yang
Dihan Zhou
Wei Shi
Benxia He
Fang Liu
Jie Yu
Ying Sun
Yuan Cao
Yaoming Li
Wenxin Li
Deying Guo
Zhijian Cao
Huimin Yan
Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7.
PLoS ONE
title Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7.
title_full Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7.
title_fullStr Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7.
title_full_unstemmed Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7.
title_short Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7.
title_sort anti hiv 1 activity of a new scorpion venom peptide derivative kn2 7
url http://europepmc.org/articles/PMC3334916?pdf=render
work_keys_str_mv AT yaoqingchen antihiv1activityofanewscorpionvenompeptidederivativekn27
AT luyangcao antihiv1activityofanewscorpionvenompeptidederivativekn27
AT maohuazhong antihiv1activityofanewscorpionvenompeptidederivativekn27
AT yanzhang antihiv1activityofanewscorpionvenompeptidederivativekn27
AT chenhan antihiv1activityofanewscorpionvenompeptidederivativekn27
AT qiaolili antihiv1activityofanewscorpionvenompeptidederivativekn27
AT jingyiyang antihiv1activityofanewscorpionvenompeptidederivativekn27
AT dihanzhou antihiv1activityofanewscorpionvenompeptidederivativekn27
AT weishi antihiv1activityofanewscorpionvenompeptidederivativekn27
AT benxiahe antihiv1activityofanewscorpionvenompeptidederivativekn27
AT fangliu antihiv1activityofanewscorpionvenompeptidederivativekn27
AT jieyu antihiv1activityofanewscorpionvenompeptidederivativekn27
AT yingsun antihiv1activityofanewscorpionvenompeptidederivativekn27
AT yuancao antihiv1activityofanewscorpionvenompeptidederivativekn27
AT yaomingli antihiv1activityofanewscorpionvenompeptidederivativekn27
AT wenxinli antihiv1activityofanewscorpionvenompeptidederivativekn27
AT deyingguo antihiv1activityofanewscorpionvenompeptidederivativekn27
AT zhijiancao antihiv1activityofanewscorpionvenompeptidederivativekn27
AT huiminyan antihiv1activityofanewscorpionvenompeptidederivativekn27